Fig. 3: The effect of LINC01133 on clinical features. | Cell Death & Disease

Fig. 3: The effect of LINC01133 on clinical features.

From: LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-FUS-FSP1 complex

Fig. 3

A The expression of LINC01133 between the tumor samples (T) and the adjacent normal tissues (N) in CESC, COAD, LUSC, OV, PAAD, READ, and STAD. B The expression of LINC01133 among different clinical stages of PAAD. C, D The prognosis of the high-LINC01133 and the low-LINC01133 group of PAAD (C) and ACC (D) in TCGA. CESC cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD colon adenocarcinoma, LUSC lung squamous cell carcinoma, OV ovarian serous cystadenocarcinoma, PAAD pancreatic adenocarcinoma, READ rectum adenocarcinoma, STAD stomach adenocarcinoma, ACC adrenocortical carcinoma. The Student t-test, one-way ANOVA, and log-rank test were used for the statistical analysis. NS means p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

Back to article page